QIAGEN announces 2028 strategy for solid profitable growth
Qiagen N.V. Common Shares (QGEN)
Last qiagen n.v. common shares earnings: 2/4 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
corporate.qiagen.com/investor-relations
Company Research
Source: GlobeNewswire
Venlo, the Netherlands, and New York, June 17, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) will announce today at its Capital Markets Day a commitment to deliver solid profitable growth through 2028 – led by about 7% compound annual sales growth (CAGR) at constant exchange rates (CER) during the four-year period and achieving at least a 31% CER adjusted operating income margin in 2028. The event, which starts at 12:00 New York time / 17:00 London time / 18:00 Frankfurt time at the New York Stock Exchange, will feature presentations and a Q&A session with Thierry Bernard, CEO of QIAGEN, along with Roland Sackers (CFO), Nitin Sood (Head of Life Sciences), Fernando Beils (Head of Molecular Diagnostics) and Jonathan Sheldon (Head of QIAGEN Digital Insights). A live webcast is available at https://capitalmarketsday2024.qiagen.com/home/default.aspx. A replay and related materials will be available at this link after the event. QIAGEN’s leadership
Show less
Read more
Impact Snapshot
Event Time:
QGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QGEN alerts
High impacting Qiagen N.V. Common Shares news events
Weekly update
A roundup of the hottest topics
QGEN
News
- QIAGEN welcomes new U.S. guidelines for use of QuantiFERON-TB Gold Plus in detecting tuberculosis infections in children [Yahoo! Finance]Yahoo! Finance
- QIAGEN welcomes new U.S. guidelines for use of QuantiFERON-TB Gold Plus in detecting tuberculosis infections in childrenGlobeNewswire
- Qiagen (NYSE: QGEN) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $50.00 price target on the stock.MarketBeat
- QIAGEN's (QGEN) New QCI Interpret Release Enhances AI Functions [Yahoo! Finance]Yahoo! Finance
- Qiagen (NYSE: QGEN) had its price target raised by analysts at JPMorgan Chase & Co. from $52.00 to $54.00. They now have an "overweight" rating on the stock.MarketBeat
QGEN
Earnings
- 4/29/24 - Beat
QGEN
Sec Filings
- 6/24/24 - Form 6-K
- 6/6/24 - Form 6-K
- 5/31/24 - Form SD
- QGEN's page on the SEC website